These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer. Hua J, Li L, Liu L, Liu Q, Liu Y, Chen X. Nucl Med Commun; 2021 Nov 01; 42(11):1247-1253. PubMed ID: 34269750 [Abstract] [Full Text] [Related]
6. An Investigation of the Relationship Between 18F-FDG PET/CT Parameters of Primary Tumors and Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer. Kandemir O, Demir F. Curr Radiopharm; 2024 Nov 01; 17(1):111-116. PubMed ID: 37644744 [Abstract] [Full Text] [Related]
7. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer. Nakanishi K, Nakamura S, Sugiyama T, Kadomatsu Y, Ueno H, Goto M, Ozeki N, Fukui T, Iwano S, Chen-Yoshikawa TF. BMC Cancer; 2021 Sep 02; 21(1):983. PubMed ID: 34474680 [Abstract] [Full Text] [Related]
8. Prediction of occult lymph node metastasis using SUV, volumetric parameters and intratumoral heterogeneity of the primary tumor in T1-2N0M0 lung cancer patients staged by PET/CT. Ouyang ML, Xia HW, Xu MM, Lin J, Wang LL, Zheng XW, Tang K. Ann Nucl Med; 2019 Sep 02; 33(9):671-680. PubMed ID: 31190182 [Abstract] [Full Text] [Related]
11. Prediction of Occult Lymph Node Metastasis Using Tumor-to-Blood Standardized Uptake Ratio and Metabolic Parameters in Clinical N0 Lung Adenocarcinoma. Ouyang ML, Tang K, Xu MM, Lin J, Li TC, Zheng XW. Clin Nucl Med; 2018 Oct 02; 43(10):715-720. PubMed ID: 30106864 [Abstract] [Full Text] [Related]
12. Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2. Pahk K, Chung JH, Yi E, Kim S, Lee SH. Eur J Radiol; 2018 Sep 02; 106():145-149. PubMed ID: 30150037 [Abstract] [Full Text] [Related]
13. Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer. Aktas GE, Karamustafaoğlu YA, Balta C, Süt N, Sarikaya İ, Sarikaya A. Nucl Med Commun; 2018 Nov 02; 39(11):995-1004. PubMed ID: 30188416 [Abstract] [Full Text] [Related]
14. Metabolic parameters using ¹⁸F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma. Kim DH, Song BI, Hong CM, Jeong SY, Lee SW, Lee J, Ahn BC. Eur J Nucl Med Mol Imaging; 2014 Nov 02; 41(11):2051-7. PubMed ID: 24990401 [Abstract] [Full Text] [Related]
15. Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer. Li C, Tian Y, Shen Y, Wen B, He Y. AJR Am J Roentgenol; 2021 Dec 02; 217(6):1433-1443. PubMed ID: 33978465 [Abstract] [Full Text] [Related]
16. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma. Moon SH, Kim HS, Hyun SH, Choi YS, Zo JI, Shim YM, Lee KH, Kim BT, Choi JY. J Nucl Med; 2014 May 02; 55(5):743-8. PubMed ID: 24700884 [Abstract] [Full Text] [Related]
17. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer. Lin JT, Yang XN, Zhong WZ, Liao RQ, Dong S, Nie Q, Weng SX, Fang XJ, Zheng JY, Wu YL. Eur J Cardiothorac Surg; 2016 Nov 02; 50(5):914-919. PubMed ID: 27113090 [Abstract] [Full Text] [Related]